The metabolic syndrome

Alberti KGMM , Zimmet P. , Shaw J. The metabolic syndrome: a new worldwide definition. Lancet 2005; 366: 1059–62

Laaksonen D. , Lakka H. , Niskanen L. , Kaplan G. , Salonen J. , Lakka T. Metabolic syndrome and the development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 2002; 156: 1070–7

Lakka H.M. , Laaksonen D.E. , Lakka T.A. . The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709–16

Meigs J. Invited commentary: Insulin Resistance Syndrome? Syndrome X? Multiple Metabolic Syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am J Epidemiol 2000; 152: 908–11

Kahn R. , Buse J. , Ferrannini E. , Stern M. The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005; 28: 2289–304

Hanson R. , Imperatore G. , Bennett P. , Knowler W. Components of the “metabolic syndrome” and incidence of type 2 diabetes. Diabetes 2002; 51: 3120–7

Reaven G. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–607

Kannel W.B. , Dawber T.R. , Kagan A. , Revotskie N. , Stokes J. Factors of risk in the development of coronary heart disease-six-year follow-up experience. The Framingham Study. Ann Internal Med 1961; 55: 33–50

Tyroler H.A. Coronary heart disease epidemiology in the 21st century. Epidem Rev 2000; 22: 7–13

Meigs J.B. , D'Agostino RD Snr , Wilson P.W. , Cupples L.A. , Nathan D.M. , Singer D.E. Risk variable clustering in the insulin-resistance syndrome. The Framington Offspring Study. Diabetes 1997; 46: 1594–600

Braunwald E. Shattuck lecture—cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 1997; 337: 1360–9

Criqui M.H. , Barrett-Connor E. , Holdbrook M.J. , Austin M. , Turner J.D. Clustering of cardiovascular disease risk factors. Preventive Med 1980; 9: 525–33

Hjermann I. , Helgeland A. , Holme I. , Lung-Larsen G. , Leren P. The intercorrelation of serum cholesterol, cigarette smoking and body weight. The Oslo Study. Acta Med Scand 1976; 200: 479–85

Salonen J.T. , Puska P. , Kottke T.E. , Heinonen O.P. Coronary risk factor clustering patterns in eastern Finland. Int J Epidemiol 1981; 10: 203–10

Ostrander L. , Lamphiear D. Coronary risk factors in a community. Findings in Tecumseh Michigan. Circulation 1976; 53: 152–6

Gordon T. , Castelli W.P. , Hjortland M.C. , Kannel W.B. , Dawber T.R. Diabetes, blood lipids, and the role of obesity in coronary heart disease risk for women. The Framingham study. Ann Internal Med 1977; 87: 393–7

Jarrett R.J. Type 2 (non-insulin-dependent) diabetes mellitus and coronary heart disease-chicken, egg or neither? Diabetologia 1984; 26: 99–102

Vague J. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout and uric calculus disease. Am J Clin Nutrition 1956; 4: 20–34

Richer P. Nouvelle Anatomie Artistique Du Corps Humain. I. Cour Practique. Elements D'anatomie. L'homme. II. Cours Superieur. Morphologie. La Femme: Plon Edit, 1920

Kading H. Alter und Fettpolsterdicke als alleininger Maastab fur den Ernahrungszustand. Munchen Med Wchnschr 1922; 69: 433

Hille G. Die Fettpolsterdicke bei der Beurteilung des Ernahrungszustandes von Kindern. Arch Kinderheilkunde 1923; 73: 134

Himsworth H.P. Diabetes mellitus: its differentiation into insulin-senstive and insulin-insenstive types. Lancet 1936; i: 127–30

Ginsberg H. , Kimmerling G. , Olefsky J.M. , Reaven G.M. Demonstration of insulin resistance in untreated adult onset diabetic subjects with fasting hyperglycemia. J Clin Invest 1975; 55: 454–61

Reaven G.M. , Olefsky J. , Farquhar J.W. Does hyperglycaemia or hyperinsulinaemia characterise the patient with chemical diabetes? Lancet 1972; i: 1247–9

Shen S.W. , Reaven G.M. , Farquhar J.W. Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes. J Clin Invest 1970; 49: 2151–60

World Health Organization. Definition, Diagnosis, and Classification of Diabetes Mellitus and Its Complications. Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva: WHO, 1999

Expert Panel on Detection E, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)[see comment]. JAMA 2001; 285: 2486–97

Balkau B. , Charles M.A. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 1999; 16: 442–3

Einhorn D. , Reaven G.M. , Cobin R.H. , Ford E. , Ganda O.P. , Handelsman Y. . American College of Endocrinology position statement on the insulin resistance syndrome. Endocrine Practice 2003; 9: 237–52

Genuth S. , Alberti K.G. , Bennett P. , Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 3160–7

Cameron A.J. , Shaw J.E. , Zimmet P.Z. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin N Am 2004; 33: 351–75

Unwin N. , Patel S. , Bhopal R. , Fischbacher C. , White M. , Alberti G. A comparision of the prevalence and metabolic characteristics of WHO and NCEP definitions of the metabolic in three UK-based ethnic groups. Diabet Med 2003; 20(Suppl 2): 66

Edwards K. , Austin M. , Newman B. , Mayer E. , Krauss R. , Selby J. Multivariate analysis of the insulin resistance syndrome in women. Arteriosclerosis Thrombosis 1994; 14: 1940–5

Meigs JB RB D.A. , Wilson P.W. , Cupples L.A. , Nathan D.M. , Singer D.E. Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes 1997; 46: 1594–600

Scuteri A. , Najjar S.S. , Morrell C.H. , Lakatta E.G. The metabolic syndrome in older individuals: prevalence and prediction of cardiovascular events: the cardiovascular health study. Diabetes Care 2005; 28: 882–7

Stern M.P. , Williams K. , Gonzalez-Villalpando C. , Hunt K.J. , Haffner S.M. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care 2004; 27: 2676–81 [erratum Diabetes Care 2005; 28: 238]

De Backer G. , Ambrosioni E. , Borch-Johnsen K. . European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2003; 24: 1601–10

Last J.M. A Dictionary of Epidemiology, 3rd edn. New York: Oxford University Press, 1995